Christopher de Souza, PhD, MBADirector at Broadview Ventures
Christopher de Souza is a Director at Broadview Ventures where he shares responsibilities for sourcing and screening of investment opportunities, deal structuring and portfolio company board involvement. He leverages over 20 years of experience in biopharmaceutical R&D, business development and strategy to help meet the Broadview Ventures mission.
Prior to Broadview, Christopher was at Novartis and SkyePharma. He has an MBA from Rutgers University and a PhD from Louisiana State University with post-doctoral training at “The Upjohn Company” and the Joslin Diabetes Center/Harvard Medical School.
Christopher currently serves on multiple Broadview Ventures portfolio company boards, the board of MassBio, the chair of the British Heart Foundation’s Translation Grant and several other grant review committees.